Vitamin K epoxide reductase

Acronym

Definition

VKOR

Vitamin K Epoxide Reductase

References in periodicals archive	?		Acronyms browser	?		Full browser	?
The eQ-PCRT LC Warfarin Genotyping Kit is an in vitro diagnostic test for genotyping single nucleotide polymorphisms (SNPs) in the cytochrome P450 enzyme gene CYP2C9 known as CYP2C92 ( C 4 3 0 T ), C Y P 2 C 9 3 (A1075C), and an SNP in the vitamin K epoxide reductase complex I gene (VKORCI) Known as VKO-RC1 (-1639G>A). Simple closed-tube real-time PCR test by Medical Laboratory Observer Novel Oral Anticoagulant Promises Potential Benefits over Leading Treatment NEW ORLEANS -- ARYx Therapeutics (NASDAQ:ARYX) announced today that clinical data for ATI-5923, a novel vitamin K epoxide reductase (VKOR) inhibitor in Phase 2/3 development for the treatment of patients at risk of forming dangerous blood clots, were presented this week at the American Heart Association (AHA) Scientific Sessions 2008 in New Orleans, LA. ARYx Therapeutics Presents Clinical Data for ATI-5923 at American ... by Business Wire ATI-5923, like warfarin, is a selective inhibitor of VKOR, or vitamin K epoxide reductase enzyme, and has the same mechanism of anticoagulation action as warfarin. ARYx Therapeutics Inc. Commences Phase 2/3 Clinical Trial on Oral ... by Business Wire	VISS VISSOFT VISSR VISSW VisSYM VIST VISTA VISTANET VISTAS VISTE VISTEL VISTO VISTOC VISTRAC VISTTA VISU VISUAL VISWA VISYON VIT VITA VITA/TCE VITAE VITAL VITAMIN Vitamin K epoxide reductase VITAR VITAS VITC VITD VITE VITEC VITEEE VITELCO VITEMA VITEWE VITF VITI VITL VITM VITMO VITO VITP VITR VITRA VITRIOL VITRP VITS VITT VITTA VITTI	vitamin G vitamin G vitamin H vitamin H vitamin H Vitamin I Vitamin Industry Vitamin Intervention for Stroke Prevention Trial Vitamin J Vitamin J Vitamin J vitamin K vitamin K vitamin K Vitamin k 1 Vitamin k 1 Vitamin k 1 Vitamin k 2 Vitamin k 2 Vitamin k 2 Vitamin k 3 Vitamin k 3 Vitamin K Antagonist Vitamin K Deficiency Vitamin K Deficiency Vitamin K Deficiency Vitamin K Deficiency Vitamin K Deficiency Bleeding Vitamin K Deficiency in Infancy Vitamin K Dependent Protein Vitamin K epoxide reductase Vitamin K Epoxide Reductase Complex vitamin K K deficiency vitamin K K deficiency vitamin K K deficiency vitamin K K1 vitamin K K1 vitamin K K1 vitamin K K2 vitamin K K2 vitamin K K2 vitamin K K3 vitamin K K3 vitamin K K3 Vitamin K-Dependent vitamin K-dependent proteins vitamin K1 vitamin K1 vitamin K1 vitamin K2 vitamin K2 vitamin K2 vitamin K1 vitamin K1 vitamin K1 vitamin K2 vitamin K2 vitamin K2 vitamin K3 vitamin K3 vitamin K3

References in periodicals archive

Acronyms browser

Full browser

The eQ-PCRT LC Warfarin Genotyping Kit is an in vitro diagnostic test for genotyping single nucleotide polymorphisms (SNPs) in the cytochrome P450 enzyme gene CYP2C9 known as CYP2C9*2 ( C 4 3 0 T ), C Y P 2 C 9 * 3 (A1075C), and an SNP in the vitamin K epoxide reductase complex I gene (VKORCI) Known as VKO-RC1 (-1639G>A).

Simple closed-tube real-time PCR test by Medical Laboratory Observer

Novel Oral Anticoagulant Promises Potential Benefits over Leading Treatment NEW ORLEANS -- ARYx Therapeutics (NASDAQ:ARYX) announced today that clinical data for ATI-5923, a novel vitamin K epoxide reductase (VKOR) inhibitor in Phase 2/3 development for the treatment of patients at risk of forming dangerous blood clots, were presented this week at the American Heart Association (AHA) Scientific Sessions 2008 in New Orleans, LA.

ARYx Therapeutics Presents Clinical Data for ATI-5923 at American ... by Business Wire

ATI-5923, like warfarin, is a selective inhibitor of VKOR, or vitamin K epoxide reductase enzyme, and has the same mechanism of anticoagulation action as warfarin.

ARYx Therapeutics Inc. Commences Phase 2/3 Clinical Trial on Oral ... by Business Wire